Patents by Inventor Joel Pradines

Joel Pradines has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19
    Patent number: 11737999
    Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for treating post-acute sequelae of COVID-19 comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: August 29, 2023
    Assignee: AXCELLA HEALTH INC.
    Inventors: Revati Wani, Alison Schecter, Michael Hamill, Margaret Koziel, Matthew Russell, Karim Azer, Karen Lavery, Joel Pradines
  • AMINO ACID COMPOSITIONS AND METHODS FOR THE TREATMENT OF POST-ACUTE SEQUELAE OF COVID-19
    Publication number: 20230038163
    Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for treating post-acute sequelae of COVID-19 comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
    Type: Application
    Filed: July 25, 2022
    Publication date: February 9, 2023
    Inventors: Revati Wani, Alison Schecter, Michael Hamill, Margaret Koziel, Matthew Russell, Karim Azer, Karen Lavery, Joel Pradines
  • Methods for Treating Disorders Associated with Fibrosis and Systemic Sclerosis
    Publication number: 20190218299
    Abstract: Provided herein are methods for treating fibrosis, including diseases or disorders associated with fibrosis, for example systemic sclerosis.
    Type: Application
    Filed: May 19, 2017
    Publication date: July 18, 2019
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Joel PRADINES, Elma KURTAGIC
  • METHODS OF ADMINISTERING LMWH
    Publication number: 20170173070
    Abstract: Methods of treating cancer comprising administering a LMWH.
    Type: Application
    Filed: April 3, 2015
    Publication date: June 22, 2017
    Inventors: Martijn Lolkema, Birgit Schultes, Joel Pradines